Laura Jolovic

The CSTN provides the world’s largest collection of pediatric cancerous tumors for research into novel treatments. Find out more about available resources.

The FDA has approved Kymriah, the first CAR T-cell therapy for acute lymphoblastic leukemia. Find out how St. Jude is planning to use this novel treatment.

Find out what makes St. Jude Children’s Research Hospital the best pediatric cancer hospital in the nation.

Find out how a newly discovered protein can give your body’s doomed cells a second chance at life.

St. Jude scientists, in work published in the journal Neuron, used powerful analytical tools to map what is known as the “epigenetics” of the retina.

Is Ptpn6, a controlling gene, linked with the master immune switch IL-1 alpha? Can this link be mapped to help pinpoint immune system response? Find out more.

Find out how Trinity uses yoga and make-believe creatures to regain her strength and coordination after pineoblastoma, a type of childhood cancer.

Ching-Hon Pui, MD, shares how he became a leading pediatric leukemia researcher. He has advice for those pursuing their dreams.

The St. Jude Global program hosted clinicians from 17 Latin American countries to enhance the quality of pediatric cancer care around the world.

NIH seminar elucidates new guidelines for grant-funded research as well as allocation of monies to more labs.